Review ArticleReviewsR
Open Access
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, ANNA GARMPI, EMMANOUIL KALAMPOKAS, THEODOROS KALAMPOKAS, ELEFTHERIOS SPARTALIS, AFRODITE DASKALOPOULOU, SERENA VALSAMI, MICHAEL KONTOS, AFRODITI NONNI, KONSTANTINOS KONTZOGLOU, DESPINA PERREA, NIKOLAOS NIKITEAS and DIMITRIOS DIMITROULIS
Cancer Genomics & Proteomics September 2017, 14 (5) 299-313;
NIKOLAOS GARMPIS
1Second Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
CHRISTOS DAMASKOS
1Second Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
2N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece
ANNA GARMPI
3Internal Medicine Department, Laiko General Hospital, University of Athens Medical School, Athens, Greece
EMMANOUIL KALAMPOKAS
4Gynaecological Oncology Department, University of Aberdeen, Aberdeen, U.K.
THEODOROS KALAMPOKAS
5Assisted Conception Unit, Second Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
ELEFTHERIOS SPARTALIS
2N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece
AFRODITE DASKALOPOULOU
2N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece
SERENA VALSAMI
6Blood Transfusion Department, Aretaieion Hospital, Medical School, National and Kapodistrian Athens University, Athens, Greece
MICHAEL KONTOS
7First Department of Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
AFRODITI NONNI
8First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
KONSTANTINOS KONTZOGLOU
1Second Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
DESPINA PERREA
2N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece
NIKOLAOS NIKITEAS
2N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, Athens, Greece
DIMITRIOS DIMITROULIS
1Second Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
In this issue
Cancer Genomics & Proteomics
Vol. 14, Issue 5
September-October 2017
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, ANNA GARMPI, EMMANOUIL KALAMPOKAS, THEODOROS KALAMPOKAS, ELEFTHERIOS SPARTALIS, AFRODITE DASKALOPOULOU, SERENA VALSAMI, MICHAEL KONTOS, AFRODITI NONNI, KONSTANTINOS KONTZOGLOU, DESPINA PERREA, NIKOLAOS NIKITEAS, DIMITRIOS DIMITROULIS
Cancer Genomics & Proteomics Sep 2017, 14 (5) 299-313;
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, ANNA GARMPI, EMMANOUIL KALAMPOKAS, THEODOROS KALAMPOKAS, ELEFTHERIOS SPARTALIS, AFRODITE DASKALOPOULOU, SERENA VALSAMI, MICHAEL KONTOS, AFRODITI NONNI, KONSTANTINOS KONTZOGLOU, DESPINA PERREA, NIKOLAOS NIKITEAS, DIMITRIOS DIMITROULIS
Cancer Genomics & Proteomics Sep 2017, 14 (5) 299-313;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells
- Novel Imidazo[2,1-b]oxazole Derivatives Inhibit Epithelial Cell Transformation and Triple Negative Breast Cancer Tumorigenesis
- Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer
- Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair
- Triple-Negative Breast Cancer: The Progress of Targeted Therapies and Future Tendencies
- Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma
- The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
- Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells
- Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
- Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model